The educational materials for patients or educational materials for healthcare professionals included here are additional risk minimisation measures that are intended to promote the safe and effective use of the medicinal product. Risk minimisation measures are a regulatory requirement and are part of the RMP (Risk Management Plans) approved by the EMA. They are assessed at national level by the HPRA for approval in Ireland.